LanteRNA
ItalyEntry
2024
Hold
2yr
Status
Active
Who owns LanteRNA?
LanteRNA is an Italian Biotech company, currently owned by Almi Invest since 2024. It changed hands in 2015, when LBO France sold.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Almi InvestAlmi Invest (Regional funds) · 2009 · VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods
Active
LBO FranceExited 2015
2012 · 2015(3yr) · LBO France Italy · 2018 · Buyout
Trade Sale · to Vandemoortele
LBO France sold Lanterna to Vandemoortele in 2015 after 3 years.
Almi InvestActive
2024 · present(2yr) · Almi Invest (Regional funds) · 2009 · VC
More from Almi Invest (Regional funds)
Other portfolio companies in the same fund.
SwedenMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns LanteRNA?
LanteRNA is currently owned by Almi Invest, through Almi Invest (Regional funds), since 2024.
When did Almi Invest acquire LanteRNA?
Almi Invest acquired LanteRNA in 2024.
Who did LanteRNA sell to?
LBO France sold LanteRNA to Vandemoortele in 2015 (Trade Sale).
Who has owned LanteRNA over time?
LanteRNA has been through 2 private-equity ownership periods: LBO France · via LBO France Italy · 2012–2015 · sold to Vandemoortele · (Trade Sale); Almi Invest · via Almi Invest (Regional funds) · since 2024.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue